[29:00] A Relatable because so many people, as we see, are dealing with this
Food and Drug Administration PubMed PubMed No published multi year surveillance exists for adverse events, and current absence of large documented harm does not imply safety equivalence to approved therapeutics with rigorous post marketing data
Mechanistic studies using proteasome CP blockers (bortezomib and marizomib) were performed in HeLa and in HeLa cells stably overexpressing IMPDH2 (clone 522-4) to counteract toxicity due to IMPDH2 degradation
The mechanism isn't pharmaceutical interaction
On the other hand, characteristics such as having a long investment time horizon, being in a high tax bracket, or having the ability to save and invest tend to make HSAs more advantageous, given their triple-tax benefits and potential for long-term growth
Insulin resistance is a hallmark of PCOS, contributing to hyperinsulinemia and hormonal imbalances that exacerbate symptoms